Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

ClinicalTrials.gov ID: NCT05599815

Public ClinicalTrials.gov record NCT05599815. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 12:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjects With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjects with Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Study identification

NCT ID
NCT05599815
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aldeyra Therapeutics, Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2023 (Estimated)
Primary completion
May 2023 (Estimated)
Completion
May 2023 (Estimated)
Last update posted
Apr 17, 2024

2023

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Amicis Research Center - Northridge Northridge California 91324 —
University of Colorado Aurora Colorado 80045 —
South Florida Research Institute Lauderdale Lakes Florida 33309 —
Emory University - Pediatric Nephrology Atlanta Georgia 30322 —
ClinCept, LLC Bremen Georgia 30110 —
Northwest Louisiana Nephrology Shreveport Louisiana 71101 —
Nevada Kidney Disease Hypertension Center (NKDHC) Las Vegas Nevada 88901 —
East Carolina University - Nephrology Greenville North Carolina 27834 —
The Ohio State University (OSU) Wexner Medical Center Columbus Ohio 43004 —
University of Toledo Medical Center Toledo Ohio 43537 —
Southern Utah Kidney and Hypertension Center St. George Utah 84765 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05599815, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05599815 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →